New Onset Dyslipidemia After Renal Transplantation: Is There a Difference Between Tacrolimus and Cyclosporine?

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2311-2313

  Deleuze, S ^a   Garrigue, V ^a   Delmas, S ^a   Chong, G ^a   Swarcz, I ^a   Cristol, J P ^a   Mourad, G ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CHOLESTEROL; CYCLOSPORIN A; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; CHOLESTEROL; CYCLOSPORINE; DYSLIPIDEMIAS; HEMOGLOBINS; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; TACROLIMUS; TRIGLYCERIDES;

EID: 33846067636     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.125     Document Type: Article

References (9)

1. Cattran D.C., Steiner G., Wilson D.R., et al. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 91 (1979) 554
2. Drueke T.B., Abdulmassih Z., Lacour B., et al. Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 1 suppl 3 (1991) S24
3. Aakhus S., Dahl K., and Wideroe T.E. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 14 (1999) 648
4. Badiou S., Garrigue V., Dupuy A.M., et al. Small dense low-density lipoprotein in renal transplant recipients: A potential target for prevention of cardiovascular complications?. Transplant Proc 38 (2006) 2314
5. McCune T.R., Thacker II L.R., Peters T.G., et al. Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. Transplantation 65 (1998) 87
6. Vela C.G., Cristol J.P., Descomps B., et al. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. Transplant Proc 32 (2000) 398
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285 (2001) 2486
8. Lightenberg G., Hene R.J., Blankestijn P.J., et al. Cardiovascular risk factors in renal transplant patients: cyclosporine A versus tacrolimus. J Am Soc Nephrol 12 (2001) 368
9. Holdaas H., Fellstrom B., Jardine A.G., et al., ALERT Study Investigators. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361 (2003) 2024